PHIO
Phio Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
4.60 / 10
Netural
Fund flow analysis shows a 7.41/10 'good' score with net inflows across block, small, medium, large, and extra-large categories, hinting at underlying buying interest. However, the overall fund-flow trend is labeled negative, aligning with the broader cautious view. Analyst sentiment is overwhelmingly bullish (Strong Buy 100%), yet historical win rates are low, tempering conviction.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-08-15
InstitutionHC Wainwright & Co.
Times predicted1
Historical Win Rate0.0%
Is money flowing into or out of PHIO?
- PHIO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.60/10 (Netural).
